Benefits seen on multiple cholesterol measures and systolic blood pressure, but not other metabolic markers<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, July 24, 2024 (HealthDay News) — Mediterranean diet (MedDiet)-based interventions aid some cardiovascular health measures among children and adolescents, according to a review published online July 12 in\u00a0JAMA Network Open<\/em>.<\/p>\n Jos\u00c3\u00a9 Francisco L\u00c3\u00b3pez-Gil, Ph.D., from Universidad de Las Am\u00c3\u00a9ricas in Quito, Ecuador, and colleagues conducted a systematic literature review to assess the effects of MedDiet-based interventions on biomarkers of cardiometabolic health among children and adolescents.<\/p>\n Based on data from nine randomized controlled trials (577 participants; mean age, 11 years), the researchers found that MedDiet-based interventions were significantly associated with reductions in systolic blood pressure (mean difference, \u00e2\u0088\u00924.75 mm Hg), triglycerides (mean difference, \u00e2\u0088\u009216.42 mg\/dL), total cholesterol (mean difference, \u00e2\u0088\u00929.06 mg\/dL), and low-density lipoprotein cholesterol (mean difference, \u00e2\u0088\u009210.48 mg\/dL), as well as increases in high-density lipoprotein cholesterol (mean difference, 2.24 mg\/dL), compared to the control group. There were no significant associations seen for other biomarkers studied, including diastolic blood pressure, glucose, insulin, or homeostatic model assessment for insulin resistance.<\/p>\n “These findings highlight the relevance of Mediterranean diet\u00e2\u0080\u0093based interventions as a useful tool to optimize cardiometabolic health in children and adolescents,” the authors write.<\/p>\n